EDXC Stock Overview
Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Endexx Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.018 |
| 52 Week High | US$0.051 |
| 52 Week Low | US$0.01 |
| Beta | -0.034 |
| 1 Month Change | -23.22% |
| 3 Month Change | 5.12% |
| 1 Year Change | -55.85% |
| 3 Year Change | -89.99% |
| 5 Year Change | -95.82% |
| Change since IPO | -99.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| EDXC | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -15.9% | 0.08% | 1.2% |
| 1Y | -55.9% | 13.2% | 24.9% |
Return vs Industry: EDXC underperformed the US Pharmaceuticals industry which returned 13.9% over the past year.
Return vs Market: EDXC underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| EDXC volatility | |
|---|---|
| EDXC Average Weekly Movement | 26.1% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EDXC's share price has been volatile over the past 3 months.
Volatility Over Time: EDXC's weekly volatility (26%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Todd Davis | www.endexx.com |
Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market. The company provides oils, extracts, topicals, and pet products for supporting the relief of pain and inflammation for humans and pets through its e-commerce site cbdunlimited.com, as well as other online and in-store retailers. It also offers hemp-derived oils, topical skin care for skin health, and beauty products, hemp-derived creams and balms, a premium line of hemp-derived health and beauty care products, and organic, plant-based, all-natural, zero-nicotine, tobacco-free vape products, as well as PhytoBites, a hemp-derived soft chews for animals.
Endexx Corporation Fundamentals Summary
| EDXC fundamental statistics | |
|---|---|
| Market cap | US$12.10m |
| Earnings (TTM) | US$6.89m |
| Revenue (TTM) | US$4.64m |
1.3x
P/E Ratio1.9x
P/S RatioIs EDXC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EDXC income statement (TTM) | |
|---|---|
| Revenue | US$4.64m |
| Cost of Revenue | US$3.31m |
| Gross Profit | US$1.33m |
| Other Expenses | -US$5.56m |
| Earnings | US$6.89m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.014 |
| Gross Margin | 28.62% |
| Net Profit Margin | 148.63% |
| Debt/Equity Ratio | -89.2% |
How did EDXC perform over the long term?
See historical performance and comparison